RecruitingOBSERVATIONAL

Electroporation for Cancer Treatment Real World Registry

This study is a registry, which means it collects information from people who have already received a cancer treatment called electroporation. It focuses on patients with skin cancer or cancers in their digestive system. The main goal is to see how well these treatments work over a long time in real-world situations. Researchers will look at whether tumours shrink and if they return after treatment. They also want to understand any side effects people might have and if these are linked to the treatment. This helps doctors learn more about electroporation's effectiveness and safety, making sure patients get the best possible care.

At a glance

Status

Recruiting

Sponsor

Mirai Medical

Enrolment target

1,000

Start

24 Jun 2021

Estimated completion

24 Jun 2036

Skin Cancer Gastrointestinal Cancer

What is this study about?

This study is called the 'Electroporation for Cancer Treatment Real World Registry'. In simple terms, a registry is a bit like a careful record-keeping project. It collects information about treatments people have already received in their normal care, rather than testing a brand-new treatment. For this study, the focus is on a treatment called 'electroporation'. This treatment uses gentle electrical pulses to help certain medicines or substances get inside cancer cells more easily, making the treatment more effective. It's used for some types of skin cancer and cancers in the digestive system, like stomach or bowel cancer.

The main purpose of this registry is to understand how well electroporation works in the long run for these cancers when it's used in real-life medical practice. Doctors want to know important things like: do tumours shrink after treatment? And do they come back later? By collecting this information from many patients, they can get a clearer picture of the treatment's success over time. They also want to identify any side effects people might experience so they can better understand the safety of the treatment.

Ultimately, this study aims to gather important information that can help doctors make better decisions about using electroporation in the future. By learning from people who have already been treated, healthcare professionals can improve care for others facing similar cancer diagnoses. It's about making sure that treatments are as effective and safe as possible for patients.

Key takeaways

This is a registry, not a trial of a new medicine.
It collects information about existing electroporation treatments.
Focuses on skin and gastrointestinal cancers.
Aims to understand long-term treatment success and side effects.
Participation involves sharing medical data, not new treatments or visits.
Your privacy will be protected.

Who may be eligible?

This study is for people who have already had a specific type of cancer treatment. To take part, you must have been treated using either "Calcium Electroporation" or "Electrochemotherapy." These are both forms of treatment that use gentle electrical pulses.

It's also important that you are able to understand what the study involves. Before you can join, you'll need to read and understand the information provided and then give your written permission (called informed consent) to take part. There are no other specific requirements, and the study is open to adults of any age and all sexes.

There are no reasons listed that would prevent you from taking part in this study if you meet the main treatment criteria and are willing to give your consent.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Have I had Calcium Electroporation treatment?
Have I had Electrochemotherapy treatment?
Can I understand the study information?
Am I able to give written permission to take part?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this registry study, it means that information about your past treatment and your health journey will be collected and analysed. Since this is a 'real-world registry' and not a clinical trial testing a new drug, you won't be given any new medications specifically for the study. You also won't have extra hospital visits or assessments that you wouldn't normally have as part of your regular medical care. The study aims to gather information from your existing medical records and follow your health as you continue your routine check-ups with your doctors. The duration of your participation will depend on how long the study continues to collect data on long-term outcomes, but it primarily involves allowing researchers to access and use anonymised data from your medical history related to your electroporation treatment and follow-up.

Potential risks and benefits

Generally, taking part in a registry study like this has very low risks because you're not receiving any new or experimental treatments. The main aspect is allowing your existing medical information to be used for research, which is usually anonymised to protect your privacy. There's no direct personal benefit from taking part, but the information collected helps doctors learn more about electroporation, potentially improving care for future patients. You are always free to change your mind and withdraw your consent to be part of the study at any time, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Royal London Hospital
Verified postcode
London, United Kingdom· Recruiting

Common questions

What is electroporation?

Electroporation is a treatment that uses quick, gentle electrical pulses to help medicines or calcium get inside cancer cells more easily, making the treatment work better.

Do I get new treatment in this study?

No, this study is a registry. It collects information from people who have already had electroporation treatment as part of their standard care. You won't receive any new treatments specifically for this study.

What kind of cancers does this study look at?

This study focuses on skin cancer and cancers in the digestive system, such as stomach or bowel cancer, that have been treated with electroporation.

Will my personal details be kept private?

Yes, information collected for research studies is handled carefully to protect your privacy. Often, data is made anonymous so your name isn't linked to your medical details.

Can I stop taking part if I change my mind?

Absolutely, you are always free to decide to stop taking part in the study at any point, and it will not affect your medical care.

How to find out more

SEAN H KINSELLA

sean@mirai-medical.com +353 91 442 498 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.